ArticleTherapeutic advances in medical oncology2024

Cost-minimization analysis comparing subcutaneous trastuzumab at home with intravenous trastuzumab for HER2-positive breast cancer in Singapore.

Yanting Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.